PL346178A1 - Il-8 receptor antagonists - Google Patents
Il-8 receptor antagonistsInfo
- Publication number
- PL346178A1 PL346178A1 PL98346178A PL34617898A PL346178A1 PL 346178 A1 PL346178 A1 PL 346178A1 PL 98346178 A PL98346178 A PL 98346178A PL 34617898 A PL34617898 A PL 34617898A PL 346178 A1 PL346178 A1 PL 346178A1
- Authority
- PL
- Poland
- Prior art keywords
- receptor antagonists
- antagonists
- receptor
- Prior art date
Links
- 102000010681 interleukin-8 receptors Human genes 0.000 title 1
- 108010038415 interleukin-8 receptors Proteins 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
- C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/015533 WO2000005216A1 (en) | 1998-07-23 | 1998-07-23 | Il-8 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL346178A1 true PL346178A1 (en) | 2002-01-28 |
Family
ID=22267562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL98346178A PL346178A1 (en) | 1998-07-23 | 1998-07-23 | Il-8 receptor antagonists |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1098884A4 (en) |
| JP (1) | JP2002521368A (en) |
| KR (1) | KR20010106415A (en) |
| CN (1) | CN1314893A (en) |
| AU (1) | AU8594198A (en) |
| BR (1) | BR9815951A (en) |
| CA (1) | CA2338741A1 (en) |
| HU (1) | HUP0102863A3 (en) |
| IL (1) | IL140983A0 (en) |
| NO (1) | NO20010353D0 (en) |
| PL (1) | PL346178A1 (en) |
| TR (1) | TR200100219T2 (en) |
| WO (1) | WO2000005216A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10038709A1 (en) | 2000-08-09 | 2002-02-28 | Aventis Pharma Gmbh | Substituted and unsubstituted benzooxathiazoles and compounds derived from them |
| DE10046029A1 (en) * | 2000-09-18 | 2002-03-28 | Bayer Ag | indazoles |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3647819A (en) * | 1969-09-19 | 1972-03-07 | Sterling Drug Inc | Indazolylphenylureas and indazolyl-phenylthioureas |
| JPH09511998A (en) * | 1994-04-15 | 1997-12-02 | グラクソ、ウェルカム、インコーポレーテッド | Method for inducing cholecystokinin agonist activity using 1,4-benzodiazepine compound |
| JP3720395B2 (en) * | 1994-09-20 | 2005-11-24 | 京都薬品工業株式会社 | Novel heterocyclic derivative, production method thereof and pharmaceutical use thereof |
| WO1996018393A1 (en) * | 1994-12-13 | 1996-06-20 | Smithkline Beecham Corporation | Novel compounds |
| JPH11503110A (en) * | 1995-02-17 | 1999-03-23 | スミスクライン・ビーチャム・コーポレイション | IL-8 receptor antagonist |
| USRE38970E1 (en) * | 1995-10-05 | 2006-02-07 | Kyoto Pharmaceutical Industries, Ltd. | Indolyl or indolinyl derivatives and medicinal use thereof as ACAT or lipid peroxidation inhibitors |
| JP2000507556A (en) * | 1996-03-28 | 2000-06-20 | スミスクライン・ビーチャム・コーポレイション | Chemokine carboxylate indole inhibitors |
-
1998
- 1998-07-23 BR BR9815951-8A patent/BR9815951A/en not_active Application Discontinuation
- 1998-07-23 CA CA002338741A patent/CA2338741A1/en not_active Abandoned
- 1998-07-23 HU HU0102863A patent/HUP0102863A3/en unknown
- 1998-07-23 CN CN98814176A patent/CN1314893A/en active Pending
- 1998-07-23 WO PCT/US1998/015533 patent/WO2000005216A1/en not_active Application Discontinuation
- 1998-07-23 AU AU85941/98A patent/AU8594198A/en not_active Abandoned
- 1998-07-23 KR KR1020017000923A patent/KR20010106415A/en not_active Withdrawn
- 1998-07-23 EP EP98937163A patent/EP1098884A4/en not_active Withdrawn
- 1998-07-23 IL IL14098398A patent/IL140983A0/en unknown
- 1998-07-23 PL PL98346178A patent/PL346178A1/en not_active Application Discontinuation
- 1998-07-23 TR TR2001/00219T patent/TR200100219T2/en unknown
- 1998-07-23 JP JP2000561172A patent/JP2002521368A/en active Pending
-
2001
- 2001-01-22 NO NO20010353A patent/NO20010353D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002521368A (en) | 2002-07-16 |
| CA2338741A1 (en) | 2000-02-03 |
| BR9815951A (en) | 2001-03-06 |
| EP1098884A1 (en) | 2001-05-16 |
| AU8594198A (en) | 2000-02-14 |
| EP1098884A4 (en) | 2003-01-22 |
| NO20010353L (en) | 2001-01-22 |
| HUP0102863A3 (en) | 2002-05-28 |
| HUP0102863A2 (en) | 2002-03-28 |
| WO2000005216A1 (en) | 2000-02-03 |
| CN1314893A (en) | 2001-09-26 |
| IL140983A0 (en) | 2002-02-10 |
| NO20010353D0 (en) | 2001-01-22 |
| KR20010106415A (en) | 2001-11-29 |
| TR200100219T2 (en) | 2001-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL134855A0 (en) | Il-8 receptor antagonists | |
| IL131004A0 (en) | Il-8 receptor antagonists | |
| EP0912505A4 (en) | Il-8 receptor antagonists | |
| EP0907362A4 (en) | Il-8 receptor antagonists | |
| EP1000017A4 (en) | Il-8 receptor antagonists | |
| PL352232A1 (en) | Il-8 receptor antagonists | |
| IL131005A0 (en) | Il-8 receptor antagonists | |
| IL145762A0 (en) | Il-8 receptor antagonists | |
| IL146046A0 (en) | Il-8 receptor antagonists | |
| ZA988101B (en) | IL-8 receptor antagonists | |
| EP0971908A4 (en) | Il-8 receptor antagonists | |
| HUP0201302A3 (en) | Il-8 receptor antagonists | |
| EP1047424A4 (en) | Il-8 receptor antagonists | |
| EP1039903A4 (en) | Il-8 receptor antagonists | |
| EP1194143A4 (en) | Il-8 receptor antagonists | |
| IL140983A0 (en) | Il-8 receptor antagonists | |
| EP1185270A4 (en) | Il-8 receptor antagonists | |
| ZA985975B (en) | IL-8 receptor antagonists | |
| ZA985813B (en) | IL-8 receptor antagonists | |
| EP1121360A4 (en) | Il-8 receptor antagonists | |
| EP1087661A4 (en) | Il-8 receptor antagonists | |
| IL146214A0 (en) | Il-8 receptor antagonists | |
| HUP0202004A3 (en) | Il-8 receptor antagonists | |
| ZA98519B (en) | Il-8 receptor antagonists | |
| EP1237548A4 (en) | Il-8 receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |